Yu Cheng
Key Laboratory Of Precision Diagnosis And Treatment Of Gastrointestinal Tumors
Shenyang, 110001, China
Shenyang, 110001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
HER2-targeted therapy combined with multidisciplinary management in advanced gallbladder cancer: a case report with 90-month survival.
Journal: Frontiers in oncology
Published: July 20, 2025
Irinotecan plus raltitrexed as second-line treatment in locally advanced or metastatic colorectal cancer patients: a prospective open-label, single-arm, multi-center, phase II study.
Journal: BMC cancer
Published: January 22, 2024
Case report: A case of rare metastasis of gastric cancer to the axillary lymph node metastasis treated with combination immunotherapy.
Journal: Frontiers in immunology
Published: November 01, 2023
Genetic feature diversity of KRAS-mutated colorectal cancer and the negative association of DNA mismatch repair deficiency relevant mutational signatures with prognosis.
Journal: Genes & diseases
Published: October 02, 2023
Retracted: Upregulation of Serine Proteinase Inhibitor Clade B Member 3 (SERPINB3) Expression by Stromal Cell-Derived Factor (SDF-1)/CXCR4/Nuclear Factor kappa B (NF-κB) Promotes Migration and Invasion of Gastric Cancer Cells.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: July 28, 2023
BRAF L485-P490 deletion mutant metastatic melanoma sensitive to BRAF and MEK inhibition: A case report and literature review.
Journal: Frontiers in pharmacology
Published: August 14, 2022
Complete Pathologic Response of Multiple Liver Metastases and Clinical Complete Response of Rectal Cancer in a Patient with Ataxia-Telangiectasia Mutated Gene Mutations After XELOXIRI Plus Bevacizumab: A Case Report.
Journal: OncoTargets and therapy
Published: May 18, 2021
Upregulation of Serine Proteinase Inhibitor Clade B Member 3 (SERPINB3) Expression by Stromal Cell-Derived Factor (SDF-1)/CXCR4/Nuclear Factor kappa B (NF-κB) Promotes Migration and Invasion of Gastric Cancer Cells.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: October 28, 2020
Clinical outcomes of capecitabine-based versus S-1-based regimens as first-line chemotherapy in patients with unresectable or metastatic gastric cancer: a propensity score matched single-center comparison.
Journal: Journal of gastrointestinal oncology
Published: September 21, 2020
Positive Cross-Talk Between CXC Chemokine Receptor 4 (CXCR4) and Epidermal Growth Factor Receptor (EGFR) Promotes Gastric Cancer Metastasis via the Nuclear Factor kappa B (NF-kB)-Dependent Pathway.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: September 04, 2020
Last Updated: 09/26/2026